1
2
3
4
van den Bergh, R.C.N., Korfage, I.J., Borsboom, G.J.J.M., Steyerberg, E.W., Essink-Bot, M.L.
Veröffentlicht in: van den Bergh , R C N , Korfage , I J , Borsboom , G J J M , Steyerberg , E W & Essink-Bot , M L 2009 , ' Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer ' , Quality of Life Research , vol. 18 , no. 8 , pp. 1061-1066 . https://doi.org/10.1007/s11136-009-9516-9;
2009
Veröffentlicht in: van den Bergh , R C N , Korfage , I J , Borsboom , G J J M , Steyerberg , E W & Essink-Bot , M L 2009 , ' Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer ' , Quality of Life Research , vol. 18 , no. 8 , pp. 1061-1066 . https://doi.org/10.1007/s11136-009-9516-9;
2009
5
Bos, J.M., Rietveld, E., Moll, HA, Steyerberg, E.W., Luytjes, W., Wilschut, J.C., de Groot, R., Postma, M.J.
Veröffentlicht in: Bos , J M , Rietveld , E , Moll , HA , Steyerberg , E W , Luytjes , W , Wilschut , J C , de Groot , R & Postma , M J 2007 , ' The use of health economics to guide drug development decisions : Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach ' , Vaccine , vol. 25 , no. 39-40 , pp. 6922-6929 . https://doi.org/10.1016/j.vaccine.2007.07.006;
2007
Veröffentlicht in: Bos , J M , Rietveld , E , Moll , HA , Steyerberg , E W , Luytjes , W , Wilschut , J C , de Groot , R & Postma , M J 2007 , ' The use of health economics to guide drug development decisions : Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach ' , Vaccine , vol. 25 , no. 39-40 , pp. 6922-6929 . https://doi.org/10.1016/j.vaccine.2007.07.006;
2007
6
7
8
9
10